{"id":27922,"date":"2025-10-24T10:25:33","date_gmt":"2025-10-24T08:25:33","guid":{"rendered":"https:\/\/agora.xtec.cat\/inslacetania\/?p=27922"},"modified":"2025-10-24T10:25:33","modified_gmt":"2025-10-24T08:25:33","slug":"nous-avencos-en-la-lluita-contra-el-parkinson","status":"publish","type":"post","link":"https:\/\/agora.xtec.cat\/inslacetania\/revista\/nous-avencos-en-la-lluita-contra-el-parkinson\/","title":{"rendered":"Nous aven\u00e7os en la lluita contra el Parkinson"},"content":{"rendered":"

La malaltia de Parkinson \u00e9s un trastorn neurol\u00f2gic que afecta el moviment i que, amb el temps, pot causar rigidesa, tremolors i dificultats per coordinar els moviments. Encara no t\u00e9 cura, per\u00f2 els \u00faltims anys s\u2019han fet aven\u00e7os importants en la recerca per millorar la vida de les persones afectades i frenar la seva progressi\u00f3.<\/p>\n

No tots els estudis han tingut \u00e8xit. Per exemple, l\u2019antic\u00f2s prasinezumab<\/strong> ( El prasinezumab<\/strong> i el minzasolmin<\/strong> s\u00f3n medicaments que volien frenar el Parkinson evitant l\u2019acumulaci\u00f3 d\u2019una prote\u00efna al cervell) no va aconseguir els resultats esperats, i el medicament minzasolmin<\/strong> es va retirar despr\u00e9s de no demostrar efic\u00e0cia. Tot i aix\u00f2, aquests resultats ajuden els cient\u00edfics a entendre millor la malaltia i a buscar noves estrat\u00e8gies m\u00e9s efectives.<\/p>\n

Els experts creuen que cal combinar diversos tractaments per atacar el Parkinson des de diferents angles, en comptes de centrar-se nom\u00e9s en un sol mecanisme. Un avan\u00e7 concret \u00e9s la <\/span>ter\u00e0pia cel\u00b7lular Bemdaneprocel<\/strong>, que busca reempla\u00e7ar les neurones que produeixen dopamina i ja ha mostrat resultats positius inicials; es preveu que entri en fase el 2025.<\/span><\/p>\n

<\/div>\n

El futur del Parkinson<\/h4>\n

Segons el doctor Diego Santos Garc\u00eda, un dels especialistes que segueix de prop la recerca, el futur passa per combinar ter\u00e0pies<\/strong>, millorar el diagn\u00f2stic preco\u00e7<\/strong> i utilitzar la intel\u00b7lig\u00e8ncia artificial<\/strong> per fer un seguiment m\u00e9s prec\u00eds.<\/p>\n

Els assajos cl\u00ednics continuen i el 2025 es preveu un gran pas endavant en la comprensi\u00f3 del Parkinson. Tot i que encara queda cam\u00ed per rec\u00f3rrer, la investigaci\u00f3 avan\u00e7a cap a tractaments m\u00e9s segurs, personalitzats i esperan\u00e7adors.<\/p>\n

Els aven\u00e7os dels \u00faltims anys mostren que, tot i les dificultats, el futur per a les persones amb Parkinson \u00e9s cada vegada m\u00e9s optimista. Gr\u00e0cies a la investigaci\u00f3 cient\u00edfica, les noves tecnologies i la implicaci\u00f3 dels pacients, s\u2019obre una nova etapa d\u2019esperan\u00e7a en la lluita contra aquesta malaltia.<\/p>\n

\"\"<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

La malaltia de Parkinson \u00e9s un trastorn neurol\u00f2gic que afecta el moviment i que, amb el temps, pot causar rigidesa, tremolors i dificultats per coordinar els moviments. Encara no t\u00e9 cura, per\u00f2 els \u00faltims anys s\u2019han fet aven\u00e7os importants en la recerca per millorar la vida de les persones afectades i frenar la seva progressi\u00f3. […]<\/p>\n","protected":false},"author":1439,"featured_media":27955,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[136,102,266],"tags":[],"class_list":["post-27922","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticies","category-revista","category-tecno"],"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/posts\/27922","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/users\/1439"}],"replies":[{"embeddable":true,"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/comments?post=27922"}],"version-history":[{"count":2,"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/posts\/27922\/revisions"}],"predecessor-version":[{"id":28014,"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/posts\/27922\/revisions\/28014"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/media\/27955"}],"wp:attachment":[{"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/media?parent=27922"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/categories?post=27922"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/agora.xtec.cat\/inslacetania\/wp-json\/wp\/v2\/tags?post=27922"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}